Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Niu Zi-Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pharmacology of Traditional Chinese Medical Formulea, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Ti…. Hauptthemen laut MEDLINE: Autophagy, Myocardial Infarction, Cardiotonic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute myocardial infarction (AMI) is a leading cause of mortality among cardiovascular diseases, yet effective therapies for AMI are limited. Previous studies have suggested cardioprotective effects of columbianadin (CBN), but its specific role in AMI and the underlying mechanisms remain unclear. This study aims to investigate whether CBN influences AMI and to elucidate the underlying mechanisms. We conducted a network pharmacology analysis to investigate the relationship between CBN and AMI. The AMI model was established by ligating the left anterior descending (LAD) artery in C57BL/6J mice, which were subsequently administered CBN. Hypoxic H9c2 cells were utilized to evaluate the effects of CBN in vitro. Our study revealed that CBN treatment significantly reduced myocardial infarction in AMI mice. It enhanced mitochondrial function and suppressed autophagy flux in hypoxic H9c2 cells. Furthermore, CBN downregulated the expression of LC3, Beclin1, and Atg 5 genes and proteins. In response to CBN treatment, the phosphorylation levels of PI3K, Akt, and mTOR increased. Notably, RAPA attenuated the protective effect of CBN in enhancing the survival of hypoxic H9c2 cells and abolished its regulation of autophagy‐related proteins via the PI3K/Akt/mTOR signaling pathway. In conclusion, CBN reduces myocardial damage by suppressing autophagy via the PI3K/Akt/mTOR signaling pathway in AMI mice and hypoxic H9c2 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Pharmacology of Traditional Chinese Medical Formulea, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- Shcool of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
ORCID-Profile: Mao Hao-Ping
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Zi-Chang, N., Ran, A., Hui-Hui, S., Qi, J., Jun-Li, S., Yan-Xu, C., Yu-Hong, L., Shu-Fei, F., & Hao-Ping, M. (2025). Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells. Phytotherapy Research. https://doi.org/10.1002/ptr.8387
Vancouver
Zi-Chang N, Ran A, Hui-Hui S, Qi J, Jun-Li S, Yan-Xu C, et al. Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells. Phytotherapy Research. 2025. doi:10.1002/ptr.8387
BibTeX
@article{ZiChang2025,
author = {Zi-Chang, Niu and Ran, An and Hui-Hui, Shi and Qi, Jin and Jun-Li, Song and Yan-Xu, Chang and Yu-Hong, Li and Shu-Fei, Fu and Hao-Ping, Mao},
title = {Columbianadin Ameliorates Myocardial Injury by Inhibiting Autophagy Through the PI3K /Akt/ mTOR Signaling Pathway in AMI Mice and Hypoxic H9c2 Cells},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8387}
}
EUVIMED